PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.772
https://www.valueinhealthjournal.com/article/S1098-3015(12)02485-0/fulltext
Section Title :
Gastrointestinal Disorders
Section Order :
282
First Page :
A329
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02485-0&doi=10.1016/j.jval.2012.08.772